tiprankstipranks
Advertisement
Advertisement

Varex Imaging Earnings Call Balances Growth And Risk

Varex Imaging Earnings Call Balances Growth And Risk

Varex Imaging Corporation ((VREX)) has held its Q1 earnings call. Read on for the main highlights of the call.

Claim 30% Off TipRanks

Varex Imaging’s latest earnings call struck a cautiously upbeat note as management highlighted solid growth, stronger profitability and robust customer engagement, particularly in Industrial markets. Still, investors were reminded of balance-sheet pressures, GAAP/non‑GAAP gaps and regional softness in APAC, which collectively temper the otherwise constructive story.

Revenue Growth

Varex reported Q1 revenue of $210 million, up 5% year over year and landing near the high end of guidance. The performance underscores steady demand across its portfolio, with management emphasizing that growth came despite mixed regional trends and a still‑challenging macro backdrop.

Industrial Segment Outperformance

Industrial sales jumped 17% to $65 million, now 31% of total revenue, powered by cargo system shipments and repeat business. Management described Industrial as a key growth engine, pointing to attractive long‑term opportunities in security screening, inspection and non‑destructive testing.

Medical Segment Stability and CT Strength

Medical revenue held broadly flat at $145 million, representing 69% of sales, as high‑end CT components offset softer areas. The company reported growing design activity around next‑generation CT platforms, suggesting that today’s stability could translate into future medical revenue growth.

Profitability (Non‑GAAP)

Non‑GAAP gross margin reached 34%, at the high end of guidance, while non‑GAAP EBITDA rose 12% to $29 million. Non‑GAAP EPS nearly doubled to $0.19 from $0.10, reflecting improved mix, cost control and leverage from higher Industrial volumes.

Strong Customer Engagement and Pipeline

At the RSNA conference, Varex held more than 150 customer meetings and showcased integrated subsystems combining tubes, detectors and software. Management cited a larger design‑win pipeline from these interactions, with many opportunities expected to convert into revenue beginning in fiscal 2027 and beyond.

Progress on India Manufacturing Strategy

The company’s detector factory in India is already producing and shipping products worldwide, enhancing cost efficiency and regional reach. Construction of the new tube factory is largely complete, with equipment qualification under way and initial tube shipments expected in about 12 months, supporting longer‑term growth and market access.

Regional Strength in Americas and EMEA

Revenue in the Americas grew 17% year over year, driven largely by Industrial and cargo‑related demand, highlighting the region as a bright spot. EMEA also delivered a solid 7% increase, underscoring that growth pockets exist even as some markets remain pressured.

Industrial Order Activity and Product Momentum

Varex saw multiple cargo system installations and new orders in the quarter, reinforcing strong demand in security and inspection. The company also highlighted momentum in photon‑counting detectors for industrial and food inspection and continuing strength in non‑destructive testing, including linear accelerators and X‑ray tubes.

APAC Revenue Decline

APAC revenue fell 7% year over year, a clear contrast to the strength in the Americas and EMEA and a watch point for investors. Management said China, which accounts for about 17% of total revenue, remains flattish and is expected to deliver only flat to modest growth into fiscal 2026.

GAAP Profitability Weakness

On a GAAP basis, gross margin slipped to 33%, down 100 basis points versus last year, reflecting some cost and mix pressures. GAAP net income was just $2 million, or $0.05 per share, underscoring a substantial gap to non‑GAAP results that investors should factor into valuation.

Inventory Build and Cash Flow Pressure

Inventory climbed $29 million to $328 million, pushing days of inventory up by 34 days to 214 and tying up working capital. Operating cash flow was negative $16 million, and the cash balance dropped $30 million to $126 million, signaling near‑term cash‑management and execution risk.

Debt Load and Refinancing Need

Varex carries $370 million of gross debt, or about $244 million of net debt after cash, with a high‑yield note at 7.875% maturing in 2027. Management intends to refinance before late 2026, making interest costs and refinancing conditions important variables for equity holders to monitor.

Non‑GAAP Policy Change

The company revised its non‑GAAP policy to exclude gains and losses from equity‑method investments, following a strategic shift at an investee. While the move aims to better reflect core operations, it reduces comparability with prior periods and adds another layer of complexity to non‑GAAP analysis.

Tax Rate and Margin Headwinds

Varex’s Q1 tax rate came in at 27%, above the roughly 23% full‑year expectation, mainly due to the distribution of income across jurisdictions. Non‑GAAP gross margin was about 90 basis points lower than a year ago, partly because the prior period benefited from German customs duty refunds that did not repeat.

Lumpy Tender‑Driven Industrial Sales

Management cautioned that cargo and other tender‑based Industrial business is inherently episodic, with large orders driving quarter‑to‑quarter swings. Even with a healthy pipeline, this means Industrial revenue growth may be uneven, and investors should expect volatility around big project wins and deliveries.

Forward‑Looking Guidance

For Q2, Varex guided non‑GAAP revenue to $210–$225 million and non‑GAAP EPS to $0.15–$0.25, assuming a 33%–34% non‑GAAP gross margin and roughly $52 million in operating expenses. The outlook brackets Q1’s performance and implies steady but not explosive growth, while management reiterated a roughly 23% tax rate target for fiscal 2026 under the updated non‑GAAP framework.

Varex’s earnings call painted a picture of a company with healthy demand, strengthening Industrial momentum and rising non‑GAAP profitability, but also with real balance‑sheet and regional challenges. For investors, the story is one of measured optimism: execution on inventory, cash flow and refinancing will be crucial to unlocking the value implied by the growing order pipeline and design wins.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1